Replies to post #1946 on Novavax Inc (NVAX)

[LongRun8]

Meant to post this a couple of days ago when I read it initially. But the point is that Medimmune's Synagis may be losing market share. This opens the door even more for NVAX. Or maybe it makes AZN/Medimmune think more about proposing a buyout of NVAX down the road when more Ph2 data comes out (as well as Ph3).